Journal Article DZNE-2022-00248

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2021
Wiley New York, NY

Movement disorders 36(11), 2595 - 2604 () [10.1002/mds.28704]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Molecular pathways associated with α-synuclein proteostasis have been detected in genetic studies and in cell models and include autophagy, ubiquitin-proteasome system, mitochondrial homeostasis, and synaptic plasticity. However, we lack biomarkers that are representative for these pathways in human biofluids.The objective of this study was to evaluate CSF protein profiles of pathways related to α-synuclein proteostasis.We assessed CSF protein profiles associated with neurotransmitter secretion, synapse plasticity, and autophagy in 2 monocentric cohorts with α-synucleinopathy (385 PD patients and 67 DLB patients). We included 80 PD patients and 17 DLB patients with variants in the glucocerebrosidase gene to serve as proxy for accelerated α-synuclein pathology with pronounced clinical trajectories.(1) Proteins associated with neurotransmitter secretion, synaptic plasticity, and endolysosomal autophagy were lower in PD and DLB patients compared with healthy controls. (2) These patterns were more pronounced in DLB than in PD patients, accentuated by GBA variant status in both entities. (3) CSF levels of these proteins were positively associated with CSF levels of total α-synuclein, with lower levels of proteostasis proteins related to lower levels of total α-synuclein. (4) These findings could be confirmed longitudinally. PD patients with low CSF profiles of proteostasis proteins showed lower CSF levels of α-synuclein longitudinally compared with PD patients with a normal proteostasis profile.CSF proteins associated with neurotransmitter secretion, synaptic plasticity, and endolysosomal autophagy might serve as biomarkers related to α-synuclein proteostasis in PD and DLB. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyword(s): Autophagy (MeSH) ; Biomarkers (MeSH) ; Glucosylceramidase (MeSH) ; Humans (MeSH) ; Lewy Body Disease (MeSH) ; Neuronal Plasticity (MeSH) ; Neurotransmitter Agents (MeSH) ; Parkinson Disease: metabolism (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; CSF ; GBA ; PD ; lysosome ; secretion ; synaptic plasticity ; Biomarkers ; Neurotransmitter Agents ; alpha-Synuclein ; Glucosylceramidase

Classification:

Contributing Institute(s):
  1. Parkinson Genetics (AG Gasser)
  2. Core ICRU (Core ICRU)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2021
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > TÜ DZNE > TÜ DZNE-ICRU
Full Text Collection
Public records
Publications Database

 Record created 2022-04-06, last modified 2024-07-22


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)